Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 109

Sort by

Sort Order Select

Journal Articles

First-line romiplostim combined with immunosuppressive therapy for severe aplastic anemia: A prospective, single-arm, Phase II study

Blood (2025) 146 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2025-1426

Published: 2025

Journal Articles

Utility and sensitivity of wett-SA53 to measure dysgeusia associated with talquetamab, a GPRC5D×CD3 bispecific antibody, in Relapsed/Refractory multiple myeloma: Preliminary data from the talisman study

Blood (2025) 146 (Supplement 1): 5821.

https://doi.org/10.1182/blood-2025-5821

Published: 2025

Journal Articles

HDAC and CDK inhibitor combinations suppress neutrophil activation in myeloma

Snehal M Gaikwad, Tyler Peat, Wendy Du Bois, Shuling Zhang, Nana Gyabaah-Kessie, Jing Zhang, Dickran Kazandijian, Aleksandra Michalowska, Beverly Mock

Blood (2025) 146 (Supplement 1): 7475.

https://doi.org/10.1182/blood-2025-7475

Published: 2025

Journal Articles

α-synuclein aggregates inhibit reticulocyte maturation

Yijin Chen, Peizheng Yang, Yanjuan Liu, Yunfei Liu, Mengmeng Huang, Jie Zhang, Ying Yang, Meng Zhang, Jing Zhang, He Huang

Blood (2025) 146 (Supplement 1): 1117.

https://doi.org/10.1182/blood-2025-1117

Published: 2025

Journal Articles

Shared immune features correspond to high-risk multiple myeloma across multiple human subtypes and murine models

Blood (2025) 146 (Supplement 1): 5723.

https://doi.org/10.1182/blood-2025-5723

Published: 2025

Journal Articles

Boosting anti-tumor immunity in NRAS;ASXL1-driven Acute Myeloid Leukemia through combined inhibition of MEK and HDACs.

Meher Gayatri Bolisetti, Anthony Veltri, Jacqueline Cook, Bei Jia, Jing Li, Maoshou Yang, Vysakh Anandan, Jiacheng Yao, Kenneth Man Chan, Sarah Granozio, Esraa Keewan, Erik Ranheim, Xiaolan Zhu, Kalyan Nadiminti, Suresh Marulasiddappa, Hong Zheng, Xiaona You, Jing Zhang

Blood (2025) 146 (Supplement 1): 5007.

https://doi.org/10.1182/blood-2025-5007

Published: 2025

Journal Articles

A Phase I, open-label study of CTD402, a universal CD7-targeting CAR T-cell therapy, in patients with relapsed/refractory severe aplastic anemia

Lele Zhang, Ruonan Li, Jing Zhang, Jianping Li, Neng Nie, Xingxin Li, Xiao Yu, Zhexiang Kuang, Liyun Li, Jingyu Zhao, Maria del Rosario, Xiao Shi, Yong Yu, Yali Zhou, Ming Gao, Wengang Ge, Jiangtao Ren, Jan Davidson-Moncada, Jun Shi

Blood (2025) 146 (Supplement 1): 3210.

https://doi.org/10.1182/blood-2025-3210

Published: 2025

Journal Articles

Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Blood (2025) 146 (Supplement 1): 698.

https://doi.org/10.1182/blood-2025-698

Published: 2025

Journal Articles

Allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B) for refractory autoimmune hemolytic anemia

Blood (2025) 146 (Supplement 1): 5922.

https://doi.org/10.1182/blood-2025-5922

Published: 2025

Journal Articles

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Blood (2025) 146 (18): 2229–2243.

https://doi.org/10.1182/blood.2025028674

Published: 2025

Includes: Supplemental data

Journal Articles

Machine Learning Analysis Was Conducted to Construct a Novel Model for Modulating the Clinical Manifestations and Predicting the Response to Glucocorticoids in Immune Thrombocytopenia

Jing Zhang, Jia Chen, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 2570.

https://doi.org/10.1182/blood-2024-203542

Published: 2024

Journal Articles

Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Blood (2024) 144 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2024-205535

Published: 2024

Journal Articles

Antithymocyte Globulin Enhances Myeloid-Derived Suppressor Cell Expansion and Function in Severe Aplastic Anemia

Peiyuan Dong, Yilin Liu, Zhongxing Jiang, Huimin Sun, Yanhong Zhao, Linjie Wu, Jiali Huo, Jing Zhang, Meili Ge, Fang Dong, Sha Hao, Tao Cheng

Blood (2024) 144 (Supplement 1): 4073.

https://doi.org/10.1182/blood-2024-202325

Published: 2024

Journal Articles

Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 681.

https://doi.org/10.1182/blood-2024-204200

Published: 2024

Journal Articles

The Clinical Significance and Prognostic Value of Serum Beta-2 Microglobulin in Adult Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Multicenter Analysis of 326 Patients

Blood (2023) 142 (Supplement 1): 6187.

https://doi.org/10.1182/blood-2023-182677

Published: 2023

Journal Articles

Clinical Significance of Serum High-Density Lipoprotein Cholesterol and Its Dynamic Change in Patients with Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Wenyu Shi, Yi Miao, Jing Zhang, Jianyong Li

Blood (2023) 142 (Supplement 1): 4445.

https://doi.org/10.1182/blood-2023-184781

Published: 2023

Journal Articles

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

Shichong Wang, Jiali Huo, Yilin Liu, Lingyun Chen, Xiang Ren, Xingxin Li, Min Wang, Peng Jin, Jinbo Huang, Neng Nie, Jing Zhang, Yingqi Shao, Meili Ge, Yingchang Mi, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 2717.

https://doi.org/10.1182/blood-2023-178156

Published: 2023

Journal Articles

Histiocytic Necrotizing Lymphadenitis with Hemophagocytic Lymphohistiocytosis: A Single-Center Analysis of Five Cases

Yi Miao, Qingqing Chen, Wenyu Shi, Jing Zhang, Jianyong Li

Blood (2023) 142 (Supplement 1): 5379.

https://doi.org/10.1182/blood-2023-182635

Published: 2023

Journal Articles

Myeloid Dendritic Cells Were Expanded and Functionally Stronger in Aplastic Anemia

Lingyun Chen, Jiali Huo, Xiang Ren, Shichong Wang, Yilin Liu, Jinbo Huang, Xingxin Li, Min Wang, Peng Jin, Neng Nie, Jing Zhang, Yingqi Shao, Yingchang Mi, Yizhou Zheng, Meili Ge

Blood (2023) 142 (Supplement 1): 5657.

https://doi.org/10.1182/blood-2023-182739

Published: 2023

Journal Articles

The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Ting-Bo Liu, Xiaofan Li, Rui-Zhi Zhao, Han Shao, Gui-Qing Shi, Yan-Yan Qiu, Tian-Lan Tang, Yu-Ping Lin, Si-Lin Chen, Cheng Huang, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Jian-Zhen Shen, Ben-Hua Xu, Yu-jing Zhang, Yong Yang

Blood (2023) 142 (Supplement 1): 6189.

https://doi.org/10.1182/blood-2023-184773

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

First-line romiplostim combined with immunosuppressive therapy for severe aplastic anemia: A prospective, single-arm, Phase II study

Utility and sensitivity of wett-SA53 to measure dysgeusia associated with talquetamab, a GPRC5D×CD3 bispecific antibody, in Relapsed/Refractory multiple myeloma: Preliminary data from the talisman study

HDAC and CDK inhibitor combinations suppress neutrophil activation in myeloma

α-synuclein aggregates inhibit reticulocyte maturation

Shared immune features correspond to high-risk multiple myeloma across multiple human subtypes and murine models

Boosting anti-tumor immunity in NRAS;ASXL1-driven Acute Myeloid Leukemia through combined inhibition of MEK and HDACs.

A Phase I, open-label study of CTD402, a universal CD7-targeting CAR T-cell therapy, in patients with relapsed/refractory severe aplastic anemia

Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B) for refractory autoimmune hemolytic anemia

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Machine Learning Analysis Was Conducted to Construct a Novel Model for Modulating the Clinical Manifestations and Predicting the Response to Glucocorticoids in Immune Thrombocytopenia

Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Antithymocyte Globulin Enhances Myeloid-Derived Suppressor Cell Expansion and Function in Severe Aplastic Anemia

Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia

The Clinical Significance and Prognostic Value of Serum Beta-2 Microglobulin in Adult Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Multicenter Analysis of 326 Patients

Clinical Significance of Serum High-Density Lipoprotein Cholesterol and Its Dynamic Change in Patients with Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

Histiocytic Necrotizing Lymphadenitis with Hemophagocytic Lymphohistiocytosis: A Single-Center Analysis of Five Cases

Myeloid Dendritic Cells Were Expanded and Functionally Stronger in Aplastic Anemia

The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only